Skip to main content

Table 4 Opinion about the importance, effectiveness and cost-effectiveness of smoking cessation interventions by country (scale responses: 1 = strongly disagree; 7 = strongly agree)

From: Similarities and differences between stakeholders’ opinions on using Health Technology Assessment (HTA) information across five European countries: results from the EQUIPT survey

 

Netherlands

Hungary

Germany

Spain

United Kingdom

Total

Kruskal–Wallis test

Statements

n

Mean (SD)

n

Mean (SD)

n

Mean (SD)

n

Mean (SD)

n

Mean (SD)

n

Mean (SD)

P value

The smoking epidemic is not severe in my country

28

2.00 (1.39)

16

1.44 (0.89)

17

1.82 (1.13)

18

1.50 (0.86)

14

2.50 (1.65)

93

1.85 (1.251)

0.10

Most smoking cessation interventions are effective

28

3.79 (1.52)

16

2.63 (1.31)

17

2.71 (0.85)

18

4.67 (1.75)

14

4.79 (1.42)

93

3.71 (1.639)

< 10–3

Most smoking cessation interventions are cost-effective

28

4.11 (1.91)

14

2.64 (1.48)

17

3.18 (1.67)

16

4.75 (1.88)

14

5.71 (1.27)

89

4.07 (1.941)

< 10–3

It is important to use smoking cessation interventions because smoking kills a lot of people

28

6.46 (0.79)

16

6.88 (0.50)

17

5.82 (1.51)

18

6.83 (0.51)

14

6.71 (0.47)

93

6.53 (0.916)

0.009

It is important to use smoking cessation interventions because smoking costs a lot for the society

28

6.14 (1.01)

16

6.75 (0.78)

17

5.76 (1.56)

18

6.67 (0.69)

14

6.43 (0.76)

93

6.32 (1.055)

0.032

It is unacceptable that we use smoking cessation interventions without knowing their efficacy

27

5.89 (1.05)

16

6.88 (0.34)

17

5.65 (1.62)

17

5.41 (1.54)

14

5.43 (1.22)

91

5.86 (1.304)

0.003

It is unacceptable that we use smoking cessation interventions without knowing their cost-effectiveness

27

5.04 (1.56)

16

6.00 (1.41)

17

5.12 (1.73)

18

4.50 (1.79)

14

5.07 (1.39)

92

5.12 (1.623)

0.092

  1. SD, Standard deviation